Zonisamide product-specific bioequivalence guidance

This document provides product-specific guidance on the demonstration of the bioequivalence of zonisamide. Please note that no comments have been received for this guideline during the public consultation period.

KeywordsBioequivalence, generics, zonisamide

Abbreviations

  • BCS Classification: Biopharmaceutics Classification System
  • AUC0-t: area under the plasma concentration curve from administration to last observed concentration at time t
  • AUC0-72: area under the plasma concentration curve from administration to last observed concentration at 72 hours
  • Cmax: maximum plasma concentration

Topics

How useful was this page?

Add your rating